Instruction for use: Estifan

Dosage form: tablets

Active substance: Extractum herbae Echinaceae purpurae

ATX

L03AX Other immunostimulants

Pharmacological groups:

Antiseptics and disinfectants

Other immunomodulators

The nosological classification (ICD-10)

H60.3 Other infectious external otitis media: Infectious-inflammatory diseases of ENT organs; Infectious-inflammatory disease of ENT organs

J18 Pneumonia without specification of pathogens: Alveolar pneumonia; Community-acquired pneumonia atypical; Community-acquired pneumonia non-pneumococcal; Pneumonia; Inflammation of the lower respiratory tract; Inflammatory lung disease; Shared pneumonia; Respiratory and lung infections; Infections of the lower respiratory tract; Cough with inflammatory diseases of the lungs and bronchi; Croupous pneumonia; Nosocomial pneumonia; Exacerbation of chronic pneumonia; Acute community-acquired pneumonia; Acute pneumonia; Focal pneumonia; Pneumonia abscessing; Pneumonia bacterial; Pneumonia croupy; Pneumonia of focal; Pneumonia with difficulty in sputum discharge; Pneumonia in AIDS patients; Pneumonia in children; Septic pneumonia; Chronic Obstructive Pneumonia; Chronic pneumonia; Lymphoid interstitial pneumonia

J22 Acute respiratory infection of lower respiratory tract, unspecified: Bacterial respiratory disease; Bacterial infections of the lower respiratory tract; Bacterial infections of the respiratory system; Viral respiratory disease; Viral respiratory tract infections; Inflammatory respiratory disease;; Difficult sputum separation in acute and chronic respiratory diseases; Respiratory tract infections; Respiratory and lung infections; Lower respiratory tract infections; Infections of the lower respiratory tract; Infectious inflammation of the respiratory tract; Infectious diseases of the respiratory tract; Infectious diseases of the lungs; Infectious diseases of the respiratory system; Respiratory tract infection; Cough for colds; Pulmonary infection; Acute respiratory tract infection; Acute respiratory viral infection; Acute inflammatory airway disease; Acute respiratory disease; Respiratory infection; Respiratory and viral infections; Respiratory syncytial viral infection in young children; Respiratory diseases; Respiratory infections

J30-J39 Other diseases of the upper respiratory tract: Chronic diseases of the upper respiratory tract

J39.9 Disease of upper respiratory tract, unspecified: Mechanical irritation of mucosa of upper respiratory tract; Acute respiratory disease; Recurrent infections of ENT organs; Chronic infection of the upper respiratory tract; Chronic infections of ENT organs; Infections of ENT organs

J42 Chronic bronchitis, unspecified: Recurrent bronchitis; Asthmatic bronchitis; Asthmatic bronchitis; Bronchitis chronic; Inflammatory respiratory disease; Disease of the bronchi; Qatar smoker; Cough with inflammatory diseases of the lungs and bronchi; Exacerbation of chronic bronchitis; Chronic bronchitis; Chronic Obstructive Pulmonary Diseases; Chronical bronchitis; Chronic bronchitis of smokers; Chronic spasmodic bronchitis; Allergic bronchitis; Bronchitis allergic

J44.9 Chronic obstructive pulmonary disease, unspecified: Obstructive pulmonary pathology; Bronchial obstruction; Bronchoobstructive syndrome; Exacerbation of chronic obstructive pulmonary disease; Reversible bronchial obstruction; Reversible airway obstruction; Panbronchiolitis; Panbronchitis; COPD; Chronic lung infection; Chronic infection of the lower respiratory tract; Chronic obstructive pulmonary disease; Chronic Obstructive Pneumonia; Chronic lung diseases; Chronic Obstructive Pulmonary Diseases; Chronic bronchopulmonary disease; Chronic broncho-pulmonary diseases; Obstruction of the respiratory tract

Composition and release form

1 tablet contains a dry extract from the echinacea of the purple family of astrovs 0.2 g; In banks of dark glass for 30 pcs.

Pharmachologic effect

Mode action - immunostimulating.

Increases nonspecific resistance of the body, increases the functional activity of phagocytes, bone marrow and spleen cells, enhances antibody formation.

Indications for the preparation Estifan

Chronic lung diseases, recurrent infections, ENT diseases.

Contraindications

Hypersensitivity.

Side effects

Allergic reactions.

Dosing and Administration

Dosing and Administration Inside, after meals, 0.2 g 3 times a day for 25 days, or 0.4 g 3 times a day for 5 days, then - 0.2 g 3 times a day for 20 days.

Storage conditions of the drug Estifan

In a dry, the dark place at a temperature below 25 ° C.

Keep out of the reach of children.

Shelf life of the drug Estifan

2 years.

Do not use after the expiry date printed on the package.